Comparative analysis of predictability and accuracy of American Society of Cataract and Refractive Surgery online calculator with Haigis-L formula in post-myopic laser-assisted


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 15 5 2021
Statut: ppublish

Résumé

The aim of this study was to compare the predictability and accuracy of the American Society of Cataract and Refractive Surgery (ASCRS) online calculator with the Haigis-L formula for intraocular lens (IOL) power calculation in post myopic laser-assisted in-situ keratomileuses (LASIK) eyes undergoing cataract surgery and also to analyze the postoperative refractive outcome among the ASCRS average, maximum and minimum values. A retrospective study was conducted on post myopic LASIK eyes which underwent cataract surgery between June 2017 and December 2019. IOL power was calculated using both Haigis-L & ASCRS methods. Implanted IOL power was based on the ASCRS method. The expected postoperative refraction for IOL power based on the Haigis-L formula was calculated and compared with the Spherical Equivalent (SE) obtained from the patient's actual refraction. Prediction error (PE) & Mean Absolute Error (MAE) was calculated. Intragroup analysis of ASCRS values was done. Among the 41 eyes analyzed, pre-operative and post-operative mean best-corrected visual acuity was 0.58 ± 0.21 and 0.15 ± 0.26 logMAR, respectively. In the ASCRS method, 36 (87.8%) and 40 (97.6%) eyes had PE within ± 0.5D and ± 1.0 D, respectively, whereas, in the Haigis-L method, 29 (70.7%) eyes, and 38 (92.7%) eyes had PE within ± 0.5D and ± 1.0 D, respectively. Among the ASCRS subgroups, ASCRS average, maximum and minimum values had 83%, 80.6%, and 48.8% eyes with SE within ± 0.5D, respectively. ASCRS method can be considered as an equally efficient method of IOL power calculation as the Haigis-L method in eyes which have undergone post myopic LASIK refractive surgery. ASCRS maximum & average values gave better emmetropic results.

Identifiants

pubmed: 33229682
pii: IndianJOphthalmol_2020_68_12_2985_301254
doi: 10.4103/ijo.IJO_2494_20
pmc: PMC7856948
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2985-2989

Déclaration de conflit d'intérêts

None

Références

J Cataract Refract Surg. 2013 Sep;39(9):1327-35
pubmed: 23860012
Ophthalmology. 2015 Dec;122(12):2443-9
pubmed: 26459996
J Cataract Refract Surg. 2016 Jan;42(1):163-70
pubmed: 26948792
Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):332-338
pubmed: 28780776
Clin Exp Optom. 2019 Mar;102(2):154-159
pubmed: 30380588
J Cataract Refract Surg. 2010 Sep;36(9):1466-73
pubmed: 20692556
J Cataract Refract Surg. 2012 Apr;38(4):589-94
pubmed: 22440433
Curr Opin Ophthalmol. 2017 Jan;28(1):16-22
pubmed: 27748658
Am J Ophthalmol Case Rep. 2019 Jun 13;15:100495
pubmed: 31249905
Korean J Ophthalmol. 2017 Dec;31(6):479-488
pubmed: 28913996
J Cataract Refract Surg. 2008 Oct;34(10):1658-63
pubmed: 18812114
Eye Vis (Lond). 2020 May 1;7:37
pubmed: 32656291
Ophthalmic Physiol Opt. 2020 Sep;40(5):531-539
pubmed: 32696501
J Cataract Refract Surg. 2020 Jan;46(1):2-7
pubmed: 32050225

Auteurs

P Ramya Menon (PR)

Department of Cataract and IOL Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Madhu Shekhar (M)

Department of Cataract and IOL Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

R Sankarananthan (R)

Department of Cataract and IOL Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Neha Agarwal (N)

Department of Cataract and IOL Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

C A Dhanya (CA)

Department of Cataract and IOL Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Hiruni K Wijesinghe (HK)

Consultant in Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH